Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
pioglitazone (actos) (1 trial)
Adrenoleukodystrophy (Phase 2)
Trials (1 total)
Trial APIs (1 total)